Medication Audit Checklist - Esketamine (Spravato) - Texas

Medication Audit Checklist - Esketamine (Spravato) is a legal document that was released by the Texas Health and Human Services - a government authority operating within Texas.

FAQ

Q: What is the medication Esketamine (Spravato)?
A: Esketamine, brand name Spravato, is a medication used to treat depression.

Q: Is Esketamine approved by the FDA?
A: Yes, Esketamine (Spravato) is approved by the FDA as a treatment for depression.

Q: How is Esketamine administered?
A: Esketamine is administered as a nasal spray.

Q: Who can prescribe Esketamine?
A: Only healthcare providers enrolled in the Spravato REMS (Risk Evaluation and Mitigation Strategy) program can prescribe Esketamine.

Q: Is Esketamine covered by insurance?
A: Coverage for Esketamine may vary depending on your insurance provider and specific plan. It is recommended to contact your insurance company for more information.

Q: What are the potential side effects of Esketamine?
A: Common side effects of Esketamine may include nausea, dizziness, dissociation, headache, and increased blood pressure.

Q: How often is Esketamine administered?
A: The initial recommended dosage is twice a week for the first month, followed by once weekly or every other week depending on the individual's response.

Q: Is Esketamine suitable for everyone with depression?
A: Esketamine is specifically indicated for adults with treatment-resistant depression who have not responded to other antidepressant medications.

Q: Can Esketamine be used in combination with other antidepressants?
A: Yes, Esketamine treatment may be used in combination with an oral antidepressant.